Skip to main content
CDIO logo

Cardio Diagnostics Holdings, Inc.

CDIONASDAQHealthcareBiotechnology

$1.71Today:- (-)1Y −58.93%

As of Oct 16, 2026 close

Market cap
$5.21M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.97$7.91
Volume (live)
-
Avg. volume (3M)
31.77K

Cardio Diagnostics Holdings (CDIO) Income Statement

Cardio Diagnostics Holdings reported revenue of $14.82K in fiscal 2025 (fiscal year ended Dec 31, 2025), down 57.5% from $34.89K a year earlier. Cardio Diagnostics Holdings posted a net loss of $6.50M, compared with a net loss of $8.38M a year earlier. Gross margin was 100.0% and operating margin -43737.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $5.36K, down 28.3% from the same quarter a year earlier.

Cardio Diagnostics Holdings Income Statement Analysis

Values in millions USD

Scroll to see more
Cardio Diagnostics Holdings, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.010.030.020.000.000.00
Cost of Revenue0.000.000.000.000.000.00
Gross Profit0.010.030.020.000.000.00
Operating Expenses
Research & Development0.640.230.150.040.030.00
Selling, General & Administrative5.798.157.104.490.570.60
Operating Expenses6.508.407.264.550.620.61
Operating Income-6.48-8.37-7.24-4.55-0.62-0.61
Other Income/Expense
Interest Income0.000.000.000.000.000.00
Interest Expense0.010.026.740.000.000.00
Other Income/Expense-0.01-0.02-1.13-0.110.000.00
Income
Income Before Tax-6.50-8.38-8.38-4.66-0.62-0.61
Income Tax Expense0.000.000.000.000.000.00
Net Income-6.50-8.38-8.38-4.66-0.62-0.61
Net Income - Continuous Operations-6.50-8.38-8.38-4.66-0.62-0.61
Net Income - Discontinued Operations------
EBITDA-6.09-8.09-1.53-4.64-0.60-0.60
EBIT-6.48-8.36-7.24-4.66-0.62-0.61
Depreciation & Amortization0.070.020.110.020.020.01
Earnings Per Share
Basic EPS-4.00-9.00-20.00-45.00-16.00-
Diluted EPS-4.00-9.00-20.00-45.00-16.00-
Basic Shares Outstanding1.750.900.423.090.049.52
Diluted Shares Outstanding1.750.900.423.090.049.52

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cardio Diagnostics Holdings Financial Statements

What was Cardio Diagnostics Holdings's revenue in fiscal 2025?

Cardio Diagnostics Holdings reported revenue of $14.82K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 57.5% from $34.89K a year earlier.

Is Cardio Diagnostics Holdings profitable?

No. Cardio Diagnostics Holdings reported a net loss of $6.50M in fiscal 2025. In fiscal 2024 it lost $8.38M.

What is Cardio Diagnostics Holdings's operating margin?

Cardio Diagnostics Holdings's operating income was −$6.48M on revenue of $14.82K in fiscal 2025, an operating margin of -43737.5%, compared with -23977.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition